novo oral semaglutide Shows Promise in Adolescents with Type 2 Diabetes Business | Novo Nordisk has

Description

GLP-1 receptor agonists such as semaglutide are primarily designed for blood sugar control and weight management, but emerging research suggests indirect effects on stress hormone pathways

Por qu encaja bien en una rutina con GLP-1

GLP-1 agents have reshaped the management of obesity, and the market continues to accelerate as new agents and indications emerge

Compared with SGLT-2 inhibitor use, GLP-1 receptor agonist use was not associated with an increased risk of pulmonary aspiration (pooled risk ratio 0.98, 95% CI 0.73 to 1.31), although it was associated with a higher risk for discontinuation of endoscopy (1.99, 1.56 to 2.53)

Ozempic and Mounjaro are part of a class of drugs called GLP-1 receptor agonists, which act by mimicking hormones in the gut involved in insulin regulation and appetite.